Comment on Zhang et Al. Second-line agents for glycemic control for type 2 diabetes: are newer agents better? Diabetes Care 2014;37:1338-1345
Diabetes Care
.
2014 Sep;37(9):e204.
doi: 10.2337/dc14-1041.
Authors
Jay Bae
1
,
Bradley H Curtis
2
,
David M Kendall
1
,
Robert J Heine
1
Affiliations
1
Eli Lilly and Company, Indianapolis, IN.
2
Eli Lilly and Company, Indianapolis, IN
[email protected]
.
PMID:
25147265
DOI:
10.2337/dc14-1041
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 2 / prevention & control*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Male
Substances
Hypoglycemic Agents